A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in type 2 (non-insulin-dependent) diabetes
Diabetologia1982Vol. 23(6), pp. 507–10
Citations Over TimeTop 16% of 1982 papers
Related Papers
- → Improved glycaemic control with metformin–glibenclamide combined tablet therapy (Glucovance®) in Type 2 diabetic patients inadequately controlled on metformin(2002)84 cited
- Comparison of effect of metformin in combination with glimepiride and glibenclamide on glycaemic control in patient with type 2 diabetes mellitus.(2009)
- → Effects of Metformin and Metformin Plus Glibenclamide on Glucose-6- Phosphatase Status and Some Biochemical Parameters in Type 2 Diabetic Patients(2016)2 cited
- Survey on serum lipids in grown-ups living in Lingwu district(2006)
- Lower post prandial glucose excursion and better lipid contrl by treatment with metformin/glibenclamide combination tablet (Glucovance®) in comparison to metformin + glibenclamide coadministered separately to patients with type 2 diabetes (DM2)(2007)